Short Interest in Sunshine Biopharma, Inc. (NASDAQ:SBFM) Expands By 24.9%

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 141,300 shares, a growth of 24.9% from the March 15th total of 113,100 shares. Currently, 3.9% of the shares of the stock are sold short. Based on an average daily volume of 1,160,000 shares, the days-to-cover ratio is currently 0.1 days.

Hedge Funds Weigh In On Sunshine Biopharma

A hedge fund recently bought a new stake in Sunshine Biopharma stock. Connective Capital Management LLC bought a new position in Sunshine Biopharma, Inc. (NASDAQ:SBFM) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 11,345 shares of the company’s stock, valued at approximately $34,000. Connective Capital Management LLC owned approximately 0.93% of Sunshine Biopharma at the end of the most recent reporting period. 41.98% of the stock is owned by hedge funds and other institutional investors.

Sunshine Biopharma Stock Performance

Shares of SBFM stock opened at $1.25 on Friday. Sunshine Biopharma has a fifty-two week low of $1.17 and a fifty-two week high of $33.60. The stock’s fifty day moving average is $2.02 and its two-hundred day moving average is $2.56. The firm has a market capitalization of $3.38 million, a P/E ratio of -0.01 and a beta of 1.32.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.